Skip Navigation
  Search Menu
Find an Expert


Karim Boudadi, M.D.

Photo of Dr. Karim Boudadi, M.D.

Assistant Professor of Oncology


Languages: English, French, Spanish

Expertise: Anemias, Blood Cancers, Blood Disorders, Head and Neck Cancers, Head and Neck Tumors, Hematologic Malignancies, Hematology, Medical Oncology, Oncology, Prostate Cancer, Sarcoma more

Research Interests: Immunotherapy


Sibley Memorial Hospital

5255 Loughboro Road NW
Johns Hopkins Kimmel Cancer Center
Washington, DC 20016 map
Phone: 202-660-6500
Fax: 202-660-6501


Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C. and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Boudadi is board certified in medical oncology, hematology, and internal medicine by the American Board of Internal Medicine. 

Dr. Boudadi has expertise in treating a wide range of cancers such as cancers of the head and neck, cancers of the esophagus, bone and soft tissue sarcomas, and prostate cancer. Having completed dual training in medical oncology and hematology at Johns Hopkins, Dr. Boudadi also sees patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders and clotting disorders. 

Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy.

Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. 

Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. more


  • Assistant Professor of Oncology

Departments / Divisions

  • Medicine at Sibley Memorial Hospital
  • Oncology - Medical Oncology



  • MD, University of Rochester School of Medicine and Dentistry (2010)


  • University of Michigan Health System / Internal Medicine (2013)


  • Johns Hopkins University School of Medicine / Oncology (2017)

Board Certifications

  • American Board of Internal Medicine / Hematology (2017)
  • American Board of Internal Medicine / Internal Medicine (2013)
  • American Board of Internal Medicine / Medical Oncology (2017)

Research & Publications

Selected Publications

View all on Pubmed

Maughan, B.L., Suzman, D.L., Luber, B., Wang, H., Glavaris, S., Hughes, R., Sullivan, R., Harb, R., Boudadi, K., Paller, C., Eisenberger, M., Demarzo, A., Ross, A., Antonarakis, E.S. "Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer." Cancer Chemother Pharmacol. 2016 Dec;78(6):1297-1304. Epub 2016 Nov 8.

Boudadi, K., Antonarakis, E.S. "Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer." Clin Med Insights Oncol. 2016 Mar 16;10(Suppl 1):1-9. doi: 10.4137/CMO.S34534. eCollection 2016. Review.

Boudadi, K., Chugh, R. "Diffuse hypopigmentation followed by hyperpigmentation in an african american woman with hemangiopericytoma treated with dasatinib." J Clin Diagn Res. 2014 Nov;8(11):QD01-2. Epub 2014 Nov 20.

Yadav, B.S., Bansal, A., Sharma, S.C., Javid, S.H., Anderson, B.O., Vaklavas, C., Forero, A., Ravi, V., Patel, S., Boudadi, K., Chugh, R., Morris, G.J. "A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer." Semin Oncol. 2013 Apr;40(2):135-44. doi: 10.1053/j.seminoncol.2013.01.010.

Mandairon, N., Peace, S.T., Boudadi, K., Boxhorn, C.E., Narla, V.A., Suffis, S.D., Cleland, T.A. "Compensatory responses to age-related decline in odor quality acuity: cholinergic neuromodulation and olfactory enrichment." Neurobiol Aging. 2011 Dec;32(12):2254-65. doi: 10.1016/j.neurobiolaging.2009.12.024. Epub 2010 Jan 15.

Activities & Honors


  • American Medical Association


  • American College of Physicians

    Associate Member

  • American Society of Clinical Oncology


  • American Society of Hematology


Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile